Infectious Disorders - Drug Targets

Author(s): Tuhin James Paul, Ayushreeya Banga, Ashmeen Kaur, Sonakshi Garg and Amandeep Singh*

DOI: 10.2174/0118715265291922240625054709

DownloadDownload PDF Flyer Cite As
India's Pink-Eye Mystery: Decoding the 2023 Conjunctivitis Outbreak

Article ID: e190724232040 Pages: 10

  • * (Excluding Mailing and Handling)

Abstract

The pink eye outbreak in 2023 was caused due to humid weather conditions in most regions of India. The most affected states include Delhi, Gujrat (21% cases), Maharashtra (30%), Himachal Pradesh (4%) and Karnataka (4%). The epidemiological data indicates that males have a high prevalence rate as compared to females; urban areas were most affected, and professionals as well as students were the population group that had the highest prevalence rate. The most common clinical manifestations were the presence of red eye, eye discharge, grittiness, and eyelashes being stuck together. One of the hallmarks of histopathology is a cobblestone formation of flattened nodules with central vascular centers. Conjunctivitis is a virusmediated immune response accompanied by inflammation, which proceeds the immune reaction, giving rise to vasodilation, pseudo membrane formation, and conjunctivital discharge. The gold standard for the diagnosis of Conjunctivitis is the Adenoplus kit using PCR technology; apart from this slit lamp biomicroscope can be used for the evaluation. It is the need of the hour to spread awareness about the Pink Eye disease and the measures to prevent it.

Keywords: Eye conjunctivitis, keratoconjunctivitis, adenovirus, pink eye, eye discharge, conjunctivitis outbreak.

Graphical Abstract